The literature investigating GDNF-RET signalling predominantly originates from experiments in cancer cell lines, such as SH-SY5Y neuroblastoma lines, which express RET at high levels following retinoic acid differentiation [42]. The gene discussed is RET; the disease is neuroblastoma.